Medivation Reports Second Quarter 2016 Financial Results
SAN FRANCISCO, CA--(Marketwired - August 09, 2016) - Medivation, Inc. (NASDAQ: MDVN) today reported its financial results for the quarter ended June 30, 2016 and reaffirmed full-year 2016 financial guidance. U.S. net sales of XTANDI® (enzalutamide) …